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Abstract
Aims/hypothesis. The aim of this study was to investi-
gate whether the β2-adrenergically mediated increase
in interstitial glycerol concentrations (used as an indi-
cator of local lipolysis) was impaired in the skeletal
muscle (the gastrocnemius muscle) of obese subjects
compared with in that of lean subjects, and whether
any differences in muscle lipolysis were related to dif-
ferences in intramyocellular muscle triglyceride con-
tent.
Methods. A microdialysis experiment was performed
in the gastrocnemius muscle of eight lean and eight
obese men (body fat 22.1±1.6% vs 32.7±1.6% respec-
tively). After determining baseline extracellular glyc-
erol concentrations, the probe was perfused with in-
creasing concentrations of the β2-agonist, salbutamol(doses of 1, 10 and 100 µmol/l for 45-min periods).
Local blood flow was determined using the ethanol di-
lution technique. Intramyocellular lipid content was
determined using 1H-magnetic resonance spectrosco-
py.
Results. Compared with that in lean subjects, the β2-
adrenergically mediated increase in glycerol concen-
trations (absolute and percentage change) was blunted
in obese subjects (at 100 µmol/l of salbutamol, per-
centage change 12.0±12% vs 48±12%, p<0.05). The
decrease in ethanol out : in ratio was less pronounced
in the obese individuals (p<0.05), indicating a dimin-
ished increase in local muscle blood flow. Intramy-
ocellular lipid content was comparable in both groups.
Conclusions/interpretation. The capacity to increase
skeletal interstitial glycerol concentrations during di-
rect β2-adrenergic stimulation is impaired in obese
subjects with normal intramyocellular concentrations,
suggesting that this may be an early event in the pro-
cess of triglyceride accumulation.
Keywords β-Adrenergic stimulation · Intramyocellular
lipids · Lipolysis · Obesity · Skeletal muscle
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Introduction
Obesity is associated with disturbances in skeletal
muscle fat metabolism. The uptake and/or oxidation
of fatty acids has been shown to be diminished in the
skeletal muscle of obese subjects under post-absorp-
tive conditions [1] and during β-adrenergic stimula-
tion [2], which may be a characteristic of visceral obe-
sity [1]. Oil-red O staining of muscle biopsies [3, 4]
and magnetic resonance imaging [5] have shown that
skeletal muscle triglyceride content is increased in
obese subjects, although this has not been confirmed
in all studies [6]. A strong link between increased
muscle triglyceride stores and skeletal muscle insulin
resistance has been shown in normal-weight, non-dia-
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betic subjects [7], in insulin-resistant obese Pima Indi-
ans [8] and in lean offspring of Type 2 diabetic par-
ents [9, 10]. Recent studies have indicated that the ac-
cumulation of lipid intermediates (such as long-chain
fatty acid acyl CoA and diacylglycerol) may be the di-
rect link with skeletal muscle insulin resistance, rather
than increased intramuscular triglyceride storage in
itself, through interference with insulin signalling 
[11, 12].
An imbalance between fatty acid uptake and fatty
acid oxidation/esterification may predispose obese
subjects towards the development of increased trigly-
ceride stores. Alternatively, disturbances in the regula-
tion of intramuscular lipolysis may contribute to in-
creased triglyceride storage. In rat and human skeletal
muscle, a hormone-sensitive lipase very similar to the
adipose tissue hormone-sensitive lipase has been iden-
tified [13] which can be stimulated by epinephrine and
muscle contractions [14]. Interstitial glycerol concen-
trations, as measured by microdialysis, have been
studied to obtain further insight into the regulation of
local muscle lipolysis. It has been shown that skeletal
muscle lipolysis is stimulated by catecholamines
through the β2-adrenergic receptor subtype alone [15],
and is inhibited by insulin [16]. A recent study
showed that net muscle glycerol release was compara-
ble in non-obese and obese subjects under post-
absorptive conditions and after glucose ingestion [17].
To date, our knowledge on differences in the regula-
tion of muscle lipolysis between lean and obese sub-
jects is limited.
The aim of our study was to investigate whether the
β2-adrenergically mediated increase in interstitial
glycerol (used as indicator of local lipolysis), as mea-
sured by microdialysis, was impaired in the skeletal
muscle (gastrocnemius muscle) of obese subjects
compared with in that of lean subjects. We also aimed
to ascertain whether any differences in the regulation
of interstitial glycerol concentrations between lean
and obese individuals relate to differences in the con-
tent of intramyocellular lipids (IMCL) by measuring
triglyceride levels in the gastrocnemius muscle using
magnetic resonance spectroscopy (MRS).
Subjects and methods
Subjects
Eight obese and eight lean male volunteers participated in this
study. Body density was determined by hydrostatic weighing
with simultaneous lung volume measurement (Volugraph
2000, Mijnhardt, Bunnik, The Netherlands). Body composition
was calculated according to the equation of Siri [18]. All sub-
jects were in good health as assessed by medical history and
physical examination. Furthermore, neither obese nor lean sub-
jects spent more than 2 h per week participating in organised
sports activities. The study protocol was reviewed and ap-
proved by the Ethics Committee of Maastricht University and
all subjects gave informed consent before participating in the
study.
Microdialysis experiments
All subjects were studied in the supine position after an
overnight fast. They were transported to the laboratory either
by car or by bus. On arrival, a microdialysis probe (CMA 60,
CMA Microdialysis, Solna, Sweden) was inserted percuta-
neously with a steel guide cannula into the medial portion of
the gastrocnemius muscle after anaesthetising the skin and
muscle fascia with lidocaine. The probe consisted of dialysis
tubing (30×0.6 mm, 20 Mr cut-off) glued to the end of a dou-
ble-lumen polyurethane cannula. The perfusion solvent entered
the probe through the inner cannula, passed down to the tip of
the probe, streamed upwards in the space between the inner
cannula and the outer dialysis membrane and left the probe
through the outer cannula via a side arm, from which it was
collected.
Microdialysis protocol. After insertion, the probe was perfused
with Ringer solution (147 mmol/l sodium, 4 mmol/l potassium,
2.25 mmol/l calcium and 156 mmol/l chloride) supplemented
with 50 mmol/l ethanol at a flow rate of 0.5 µl/min for 90 min
before the start of the experiment. During the first part of the
experiment, the real interstitial glycerol concentration was de-
termined using the zero flow method [19]. Microdialysate was
collected in two 20-min fractions at a flow rate of 0.5 µl/min
and in three 10-min fractions at flow rates of 1, 2.5 and
5 µl/min respectively. During the second part of the experi-
ment, probes were perfused with increasing concentrations of
the selective β2-adrenoceptor agonist, salbutamol, at a flow
rate of 5 µl/min. During each agonist-infusion period, one 15-min
dialysate collection fraction was followed by three 10-min
fractions. Dialysate glycerol concentrations were measured in
all samples collected at flow rates of 0.5, 1.0 and 2.5 µl/min.
Both dialysate glycerol and ethanol concentrations were mea-
sured in all samples collected at a flow rate of 5 µl/min. Etha-
nol concentrations were determined in both the ingoing and the
outgoing perfusion solvent to assess the ethanol out : in ratio
(as an indicator of nutritive blood flow) using the ethanol es-
cape technique as described previously [20].
Zero flow method. During the first part of the experiment, the
absolute interstitial glycerol concentration was determined us-
ing the zero flow method. The probe was perfused at a flow
rate of 0.5 µl/min for 40 min and at consecutive flow rates of
1, 2.5 and 5 µl/min for 30 min. Dialysate glycerol concentra-
tions were ln-transformed and plotted against perfusion rates.
Linear regression analysis was used to calculate the glycerol
concentration at a flow rate of zero, corresponding to the real
interstitial glycerol concentration. The ratio between the dialy-
sate glycerol concentration at 5 µl/min and the calculated inter-
stitial glycerol concentration represented the in vivo recovery
rate of the probe.
Perfusion with a β2-adrenoceptor agonist. During the second
part of the experiment, the probe was perfused with the selec-
tive β2-adrenoceptor agonist, salbutamol, and changes in inter-
stitial glycerol and ethanol were determined. The calibration
period with a flow rate of 5 µl/min was used as the baseline
measurement. The probe was subsequently perfused with 1, 10
and 100 µmol/l of salbutamol to stimulate β2-adrenoceptors.
Each dose of agonist was administered for 45 min at a flow
rate of 5 µl/min.
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Assessment of intramyocellular lipid content
The IMCL content of the gastrocnemius muscle was quantified
using 1H-MRS in a 1.5-T whole-body scanner (Philips Intera,
release 8.1.2; Philips Medical Systems, Best, The Nether-
lands). Subjects refrained from exhaustive physical exercise
the day before the measurements were taken. The lower leg
was positioned in a quadrature knee coil. Transversal scout im-
ages were made with a T2-weighted turbo spin echo sequence.
Voxel positions avoided adipose tissue depots as much as pos-
sible. The image-guided, localised 1H-MRS spectra from the
regions of interest were acquired using a point-resolved spec-
troscopy sequence (PRESS; repetition time 3000 ms, echo time
25 ms, 16 phase cycles, 1024 data points over 1000 Hz spectral
width with 128 averages) with a voxel volume of 12×11×
18 mm3. The water signal was suppressed using frequency-
selective pre-pulses. The unsuppressed water signal was used
as a reference signal. Fine shimming of the voxel was per-
formed to optimise the homogeneity of the magnetic field
within the region of interest.
The spectra were fitted in the time domain using a sophisti-
cated non-linear least-squares algorithm (AMARES [21]) in
the jMRUI software package (http://www.mrui.uab.es/mrui)
[22]. Three peaks were fitted for both IMCL and extramyocel-
lular lipid (EMCL) as described previously [23]. Briefly, prior
knowledge of the relative peak positions and area ratios was
used as a constraint in order to increase the accuracy and reli-
ability of the fitting procedure. The signals were corrected for
T1 and T2 relaxation using the T1 and T2 relaxation times as
determined by Schick et al. [24]. The corrected area of the CH2
peak of IMCL was expressed relative to the corrected area of
the water peak. The reproducibility of the IMCL measurement
(within-voxel coefficient of variation) was determined in two
subjects for three different voxels per subject by performing
two subsequent measurements with the subjects leaving the
magnet between measurements. The voxels were placed at the
same positions for the repeat measurements. The variability of
the IMCL content (between-voxel coefficient of variation) was
calculated as the variation between different voxel positions in
the same subject (n=12).
Analytical methods
Glycerol and ethanol concentrations in the dialysate from the
microdialysis experiments were determined on a Cobas Fara
centrifugal analyser (Roche Diagnostica, Basel, Switzerland).
Glycerol concentration was measured fluorimetrically using a
standard glycerol kit (Boehringer, Mannheim, Germany), with
concentrations of NADH, enzymes and buffer adjusted to
achieve accurate fluorimetric detection. The intra-assay coeffi-
cient of variation of this assay was 3.4% and the inter-assay
coefficient of variation was 7.1%. Ethanol concentration was
measured spectrophotometrically at 340 nm using a standard
ethanol kit (176290, Boehringer).
Statistical methods
All data are presented as means ± SEM. IMCL and EMCL
content were compared using an unpaired Student’s t test. The
effect of β2-adrenergic stimulation between groups was analy-
sed with two-way repeated measurements ANOVA. The rela-
tionship between IMCL and interstitial glycerol concentrations
was analysed by means of regression analysis. A p value of
less than 0.05 was regarded as statistically significant.
Fig. 1. A typical 1H-magnetic resonance spectrum of the gas-
trocnemius muscle in a lean subject (a) and an obese subject
(b). EMCL, CH2 peak of extramyocellular lipid; IMCL, CH2
peak of intramyocellular lipid; tCr, total creatine; TMA,
trimethylammonium compounds; v, relative resonance fre-
quency
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Fig. 2. Effect of salbutamol (β2-adrenoceptor agonist) on the
ethanol out : in ratio in skeletal muscle (gastrocnemius muscle)
of obese subjects (open diamonds) and lean subjects (open
squares). Date are means ± SEM. Two-way repeated measures
ANOVA: repeated measures p<0.001; group p<0.05
Fig. 3. Effect of salbutamol (β2-adrenoceptor agonist) on inter-
stitial glycerol concentration (a) and percentage increase in
glycerol (b) in skeletal muscle (gastrocnemius muscle) of
obese subjects (open diamonds) and lean subjects (open
squares). Date are means ± SEM. Two-way repeated measures
ANOVA: repeated measures p<0.001; group p<0.05
Table 1. Physical characteristics of the subjects
Lean subjects (n=8) Obese subjects (n=8)
Age (years) 56.4±1.7 54.5±1.7
Weight (kg) 73.3±2.2 99.1±2.1b
Height (m) 1.74±0.02 1.77±0.02
BMI (kg/m2) 24.1±0.3 31.6±0.7b
Body fat (%) 21.8±1.4 32.1±1.5b
WHR 0.94±0.03 1.03±0.02a
IMCL (%)c 0.55±0.12d 0.49±0.06
Values are means ± SEM. a p<0.05; b p<0.001; c expressed rel-
ative to water peak; d n=7
Results
Subjects and muscle lipids. The characteristics of the
subjects are presented in Table 1. By definition, body
fat and BMI were higher in the obese subjects. MRS
spectra were obtained in seven lean and eight obese
subjects. Representative 1H-MRS spectra for lean and
obese subjects are shown in Figure 1.The within-voxel
coefficient of variation in two subjects (with BMIs of
25.2 and 30.7) was 17.7±13.3% (mean ± SD) for
IMCL. The between-voxel coefficient of variation
(n=12) for IMCL was 39±26% (34±22% in lean and
44±30% in obese subjects). There were no differences
in the content of IMCL, expressed as percentage of
water resonance, between lean and obese subjects.
Local blood flow and local lipolysis. Basal values for
the ethanol out : in ratio tended to be lower in the
obese subjects, but differences between groups did not
reach statistical significance (Fig. 2). In both groups
there was a significant decrease (p<0.001) in the etha-
nol out : in ratio during the infusion of an increasing
dose of salbutamol, indicative of an increased local
blood flow. This decrease in ratio (increase in blood
flow) was significantly more pronounced in lean sub-
jects (p<0.05).
Probe recovery, calculated as (measured/real inter-
stitial glycerol)×100, was 29.3±5.2% (mean ± SD),
with no difference observed between lean and obese
subjects. Compared with lean subjects, basal interstiti-
al glycerol concentrations were significantly higher in
obese individuals (179±12 vs 121±20 µmol/l, p<0.05).
Both groups exhibited a dose-dependent increase in
interstitial glycerol concentrations during the infusion
of increasing doses of the β2-agonist, salbutamol(p<0.001; Fig. 3). The increase in interstitial glycerol
during perfusion with the β2-agonist was significantly
blunted in obese subjects as compared with lean sub-
jects, both when expressed as an absolute increase
(p<0.05) and as a percentage increase (100 µmol/l sal-
butamol; 12.0±12% vs 48±12%, p<0.05). IMCL con-
tent did not correlate with percentage body fat or basal
or salbutamol-induced (100 µmol/l) glycerol concen-
trations.
Discussion
In recent years, several investigations have focused on
the relationship between intramyocellular triglyceride
stores and insulin resistance in non-diabetic individu-
als [7]. Enlargement of the intramyocellular triacyl-
glycerol stores has been proposed to be of importance
in the aetiology of Type 2 diabetes mellitus, possibly
reflecting the effect of the concomitantly increased di-
acylglycerol and long-chain fatty acid concentrations
on insulin signal transduction [12]. The present study
aimed to investigate: (i) the regulation of interstitial
glycerol concentrations as a reflection of local lipoly-
sis in the gastrocnemius muscle of obese subjects; and
(ii) the IMCL content in the same muscle using 
1H-MRS.
The main findings of the present study were that
the β2-adrenergically mediated increases in interstitial
glycerol concentrations and local blood flow were sig-
nificantly blunted in obese subjects, suggesting that
regulation of muscle lipolysis is disturbed in these in-
dividuals. Furthermore, IMCL content was similar in
both groups of subjects.
Interstitial glycerol concentrations and lipolysis. Sev-
eral methodological issues can be raised with respect
to the present findings.
Firstly, since the blunted lipolytic response in obese
individuals was not accompanied by an increase in
IMCL stores, the question arises of whether the
(changes in) interstitial glycerol merely reflect the me-
tabolism of the extramyocellular fat stores. However,
it has been shown in several studies that interstitial
glycerol is regulated differently (by both insulin and
β-adrenergic stimulation) in adipose tissue as com-
pared with muscle in both lean and obese subjects [16,
25]. In addition, inhibition of lipolysis in adipose tis-
sue and skeletal muscle is mediated by separate and
specific phosphodiesterase subtypes [26]. In a previ-
ous study of the same subjects, the lipolytic and nutri-
tive blood-flow response to β1-, β2- and non-selectiveβ-adrenergic stimulation in adipose tissue was compa-
rable in lean and obese subjects [27], suggesting that
also the adipocytes between muscle bundles (EMCL)
may respond similarly in the two groups. Thus, al-
though we cannot exclude that EMCL could have con-
tributed to the interstitial glycerol concentrations to
some extent (particularly in the obese), our previous
finding suggests that the blunted β2-adrenergically
mediated lipolytic response may be a characteristic of
the IMCL stores rather than of the EMCL. As lean
and obese subjects have similar amounts of IMCL, it
is tempting to speculate that obese individuals have an
impaired capacity to increase the lipolysis of IMCL
before the accumulation of these lipids occurs. Thus,
an inability to regulate muscle lipolysis may be an
early event in the process leading to increased lipid
deposition within muscle in obesity. It was recently
reported that obese subjects are able to maintain nor-
mal IMCL stores in the presence of increased lipid ox-
idation [6]. The previously reported reduced fatty acid
uptake and/or fat oxidation in muscle of abdominally
obese subjects [1, 2, 28, 29] may be a characteristic of
the more obese subject [30], suggesting that IMCL ac-
cumulation may only occur in the presence of a re-
duced capacity to oxidise fat.
A second methodological issue that can be raised is
that, in the present study, interstitial glycerol has been
used as a measure of lipolysis. There are indications
that skeletal muscle may take up glycerol and may ex-
hibit significant glycerol kinase activity [31]. This
suggests that interstitial glycerol may not reflect the
overall rate of lipolysis, but may instead be the net re-
sult of triglyceride and glycerol metabolism in muscle
tissue and thus reflect glycerol turnover [32]. On the
basis of the above findings, we cannot exclude the
possibility that the blunted increase in interstitial glyc-
erol may also be (partly) due to differences in glycerol
metabolism, i.e. incorporation into triglyceride stores
[31] and/or uptake from plasma.
Thirdly, there may be marked heterogeneity in li-
polysis between different muscle groups [33]. Thus,
further studies are necessary to determine whether this
blunted capacity to stimulate muscle lipolysis extends
to other muscle groups.
Intramyocellular lipids and obesity. Results on the re-
lationship between IMCL and increased adiposity are
inconsistent. Pan et al. [8] showed that muscle triacyl-
glycerol content (as determined by biochemical analy-
sis) was not related to any measure of adiposity (i.e.
percentage body fat, BMI or WHR). Two studies have
shown a higher than normal IMCL content in the lean,
insulin-resistant offspring of Type 2 diabetic subjects
[9, 16] indicating that the relationship between IMCL
and insulin sensitivity may be independent of body
composition. Conversely, several studies have demon-
strated that obese subjects have a higher IMCL con-
tent than lean subjects using the oil-red O technique
[3, 4] or 1H-MRS (in obese adolescents) [5]. In the
present study, IMCL content was not significantly dif-
ferent between lean and obese subjects. The repro-
ducibility of IMCL determination by our 1H-MRS
measurement (within-voxel variation) was 17.7% in
obese subjects, which is higher than that reported
(4–12%) for measurements in the calf muscle in lean
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subjects [34]. The variability (between-voxel varia-
tion) was also higher in obese subjects than in lean
subjects (44% vs 34%), and higher than the values re-
ported previously by Hwang et al. (13–20% in lean
young males) [35]. Based on these results, it can be
estimated that with the present number of subjects, a
difference in IMCL of at least 25% was required for
detection using this method, indicating that we might
have failed to identify slight differences between
groups. As already indicated above, part of the dis-
crepancy between different studies on obesity and
IMCL accumulation in muscle may be related to dif-
ferences in the type of muscle studied (with concomi-
tant variation in lipolytic activity, muscle fibre type
and glycolytic and oxidative enzyme capacity) [35],
the degree of obesity [30] or body fat distribution [1].
Local blood flow. The capacity to stimulate nutritive
muscle blood flow seems to be blunted in obese sub-
jects. This is consistent with findings indicating a ten-
dency towards a diminished blood-flow response in
the forearm muscle of obese subjects during i.v. β-ad-
renergic stimulation [2] and insulin stimulation [36].
This attenuated blood-flow response implies that dif-
ferences between the β2-adrenergically mediated in-
crease in interstitial glycerol between lean and obese
subjects would be even higher if changes in blood
flow were taken into account. In addition to the dimin-
ished transport of metabolites from the muscle, this
reduced response may play a role in the diminished
delivery of nutrients to the muscle, and has been hy-
pothesised to be of importance in skeletal muscle in-
sulin resistance.
In conclusion, the present study demonstrates that
obese subjects have a capacity to increase interstitial
glycerol concentrations during direct β2-adrenergic
stimulation. As IMCL content was comparable in lean
and obese subjects, it can be speculated that a limited
ability to regulate muscle lipolysis is present before
the accumulation of lipids occurs within the muscle of
obese subjects.
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